Other
Aripiprazole
0
Pipeline Programs↗
3
Active Trials↗
6
Companies Involved↗
Aripiprazole is an early-stage landscape with 0 programs across 6 companies. The most active players are Otsuka, Pfizer, AstraZeneca.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
56
clinical trials
Completed42 · 75%
Terminated6 · 11%
Unknown status5 · 9%
Not yet recruiting2 · 4%
Recruiting1 · 2%
Clinical Trials
Trial Activity
56 trials
Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole
Recruiting·—·N/A·NCT06937476·108 enrolled
Page 1 of 4
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)